Sale!

Vornorexant Hydrate Tablets 2.5mg (Vorzzi® / ボルズィ錠2.5mg)

元の価格は JPY ¥6,200 でした。現在の価格は JPY ¥5,456 です。

Japanese Orexin Receptor Antagonist for insomnia treatment (Vornorexant Hydrate 2.5mg). Oral tablet for once-daily administration before bedtime. PTP 100 tablets [10 tablets x 10]. Mfd. by Taisho Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥5,704
10 - 19 12% JPY ¥5,456
20 + 18% JPY ¥5,084
SKU: VRZ-2.5-TAB Category:

Description

Product Overview / 商品概要

Vorzzi Tablets 2.5mg (ボルズィ錠2.5mg)
Generic: Vornorexant Hydrate / ボルノレキサント水和物
Therapeutic Category: Orexin Receptor Antagonist, Insomnia Treatment / オレキシン受容体拮抗薬 不眠症治療薬
Manufactured by: Taisho Pharmaceutical Co., Ltd. / 大正製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Vornorexant 2.5mg per tablet / 1錠中ボルノレキサントとして2.5mg
Additives: Lactose hydrate, Microcrystalline cellulose, Hydroxypropylcellulose, Sodium starch glycolate, Magnesium stearate / 乳糖水和物、結晶セルロース、ヒドロキシプロピルセルロース、デンプングリコール酸ナトリウム、ステアリン酸マグネシウム
Appearance: White plain tablet, identification code: T1, diameter approx. 5.5mm, thickness approx. 2.7mm, weight approx. 70mg
外観: 白色素錠、識別コード:T1、直径約5.5mm、厚さ約2.7mm、重量約70mg

Indications / 効能効果

EN: Insomnia
JA: 不眠症

Dosage and Administration / 用法用量

EN: The usual adult dose is 5mg of vornorexant orally once daily, immediately before bedtime. The dose may be adjusted according to symptoms, but should not exceed 10mg once daily.
JA: 通常、成人にはボルノレキサントとして1日1回5mgを就寝直前に経口投与する。なお、症状により適宜増減するが、1日1回10mgを超えないこととする。

Contraindications / 禁忌

EN: 2.1 Patients with a history of hypersensitivity to any component of this product. 2.2 Patients with severe hepatic impairment (Child-Pugh Class C). 2.3 Patients receiving itraconazole, posaconazole, voriconazole, clarithromycin, ritonavir-containing products, ensitrelvir fumarate, cobicistat-containing products, or ceritinib.
JA: 2.1 本剤の成分に対し過敏症の既往歴のある患者。2.2 重度の肝機能障害(Child-Pugh分類C)のある患者。2.3 イトラコナゾール、ポサコナゾール、ボリコナゾール、クラリスロマイシン、リトナビル含有製剤、エンシトレルビル フマル酸、コビシスタット含有製剤、セリチニブを投与中の患者。

Regulatory Information / 規制情報

Approval No.: 30700AMX00199000
Sales Started: November 2025 / 2025年11月
Classification Code: 87119
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36箇月

Packaging / 包装

Main Package (for sale): PTP 100 tablets [10 tablets x 10] / PTP 100錠[10錠×10]
Other Available Packages (by special order): PTP 100 tablets [10 tablets x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Vornorexant Hydrate Tablets 2.5mg (Vorzzi® / ボルズィ錠2.5mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Vornorexant Hydrate Tablets 2.5mg (Vorzzi®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.